All Articles

Japan's largest creative festival returns, transforming Tokyo with its 'Future Vintage' theme, blending heritage with cutting-edge art and design.

Brad Karp's 18-year reign ends abruptly after his ties to Jeffrey Epstein create a 'distraction,' paving the way for dealmaker Scott Barshay to lead.

Futures designer Nick Foster joins Unlikely Collaborators to challenge prediction, urging us to examine the hidden biases that shape what we see as possible.

Everest Medicines bets big on MT1013, a novel dual-action drug poised to transform treatment for millions with chronic kidney disease complications.

The semiconductor giant posted a huge Non-GAAP profit but a stunning IFRS loss for 2025. What's behind the numbers and why are investors cheering?

Canfor Pulp and Canfor Corp prepare for a critical joint earnings call on March 6 after a year of steep losses and severe market headwinds.

Two industry titans are tackling a major pain point for millions, aiming to make eye makeup safe and comfortable for all contact lens wearers.

Forum Energy Technologies has extended its $250M credit facility to 2031, a move that strengthens its balance sheet and fuels its 'FET 2030' growth plans.

Claros Mortgage Trust will report 2025 results on Feb. 18. Investors seek clarity on its strategy for navigating distress in commercial real estate.

A new partnership between Verity and Bushel connects on-farm data to clean fuel markets, promising a new era of revenue for sustainable farming practices.

Sila Realty Trust sets its 2025 earnings date. Investors are watching to see if its strategic acquisitions and dividend policy signal strength for the sector.

A new second-hand retailer is coming to Springfield, blending a founder's homecoming with a booming resale market and a mission to give back to the community.

With the appointment of industry veteran Joel Cannon, Medallion Bank signals a major push to expand its home improvement and fintech lending divisions.

Mount Logan Capital's tender offer was met with high demand, leading to a planned 12% reduction in shares and boosting key per-share metrics.

Shareholders to vote on a US$3.65 per share all-cash deal, a significant premium that will take the growing respiratory care provider private.

The global Japanese chain is targeting the family market with its first kids menu, prioritizing safety and flavor to cultivate a new generation of diners.

Life sciences giant QIAGEN defies economic headwinds with strong 2025 results, signaling aggressive growth in single-cell analysis and bioinformatics.

Competitors report record activity, pointing to a strong start for Nasdaq amid a complex backdrop of economic optimism and geopolitical uncertainty.

The insurance giant beat adjusted earnings estimates on strong operational performance, even as derivative losses weighed on its reported GAAP revenue.

Rumble has entered the short-form video war with Rumble Shorts, betting its free speech ethos and crypto tipping can carve out a niche against market giants.